The global reusable autoinjectors market is projected to grow at a CAGR value of 11.7% during the forecast period [2021 to 2026]. Reusable autoinjectors are becoming increasingly popular among patients suffering from diseases that require multiple injection doses in a day. Read More »
The global point of care hematology analyzers market is projected to grow at a CAGR value of 12.5% during the forecast period [2021 to 2026]. Point of care portable or handheld hematology analyzers use disposable cartridges with the necessary reagents and collect a patient sample using a drop of blood taken from the patients finger. Read More »
The global genitourinary robotic surgery market is projected to grow at a CAGR value of 11.5% during the forecast period [2021 to 2026]. Surgeries conducted with the help of robots are called robotic or robot assisted surgeries. Read More »
The neurovascular devices market is estimated to be valued at USD 2.87 billion in 2021 and is projected to reach USD 4.37 billion by 2026 at a CAGR of 8.75%. Read More »
The global cancer diagnostics market is predicted to grow from USD 16.7 billion in 2021 to reach USD 25.7 billion by 2026 with a CAGR of 10.7% from 2021-2026. The cancer diagnostics market size is increasing owing to factors such as rising incidence of cancer across the globe. Read More »
The bladder cancer market is estimated to be valued at USD 3.45 billion in 2021 and is projected to reach USD 4.24 billion by 2026 at a CAGR of 4.19%. The global market is spurred by rising cancer prevalence, which has resulted in drug development and technological advances. Read More »
The global bioinformatics in IVD testing market size will grow from USD 84.5 Billion in 2021 to USD 98.5 Billion by 2026, with a CAGR value of 6.5%. The Bioinformatics in the IVD Testing market will witness substantial growth mainly due to factors such as increasing prevalence of chronic diseases, genetic disorders, rising geriatric population, growing awareness related to early disease diagnosis, government initiatives for funding research activities, and increasing product launch strategies in the industry. Read More »
The global cardiopulmonary stress testing devices market will reach USD 6.7 billion from USD 3.7 billion with a CAGR value of 5% from 2021 to 2026. Read More »
The wearable injectors market is estimated to be valued at USD 5 Billion in 2021 and is projected to reach USD 11.20 Billion by 2026 at a CAGR of 17.5%. Globally, the rising occurrence of chronic conditions such as diabetes and cardiovascular diseases is likely to fuel the global wearable injector markets rise throughout the forecast period. Read More »
The COVID-19 sample collection kits market is estimated to be around USD 12.8 billion in 2021 and is projected to reach USD 14.6 billion by 2026, at a CAGR of 5.2%. Factors like the rising number of hospitals expanding testing capabilities, increasing prevalence of COVID-19, technological advancements, increasing disposable income, growing geriatric population, increasing adoption of point of care technology, rising number of new product launch activities, stringent government rules, and regulations for COVID-19 test, increasing number of people suffering from chronic diseases, are helping the market grow rapidly. Read More »